Under the direction of Dr. John D. Atlman, the mission of Core H, the Emory CFAR Immunology Core Laboratory (ICL) is to provide the Emory community with the highest quality assessments of immunological function necessary for the study of the pathogenesis, treatment, and prevention of immunodeficiency virus infections in humans and non-human primates. The ICL will achieve this mission through the following specific aims: 1. Flow cytometry. We will maintain a state-of-the-art flow cytometry facility, providing users with access to well maintained and calibrated instruments;""""""""full service"""""""" flow cytometry services;cell sorting, including at the BSL-3 level;and training in instrument operation, panel design and data analysis. 2. Antibody responses. We will provide a carefully selected set of services that do not duplicate activities that are standard in potential client laboratories. We will focus on binding antibodies using ELISA and ASC assays (antibody secreting cells) and on isolation of human and non-human primate monoclonal antibodies derived from mRNA isolated for sorted single cells. 3. Luminex analysis. We will provide multiplexed assays of cytokines in human and rhesus samples. 4. PBMC repository. We will continue our rhesus PBMC repository, and, in collaboration with Core D, add a new repository of highly characterized human PBMC samples derived from leukapharesis procedures. 5. T cell responses. We will continue to provide ELISpot and ICS assays, and we will add innovative new approaches to antigen delivery for T cell assays using viral vectors. We will help users relieve bottlenecks in MHC tetramer analysis by providing novel high-throughput methods for tetramer construction and by providing users with combinatorial tetramers including fluorophores that are not available from other sources. 6. We will continue to promote immunological assay education and training opportunities for CFAR investigators, the AIDS research community in Atlanta, and other National and International AIDS researchers.
Through the provision of advanced immunological assays, the numerous projects supported by Core H will be instrumental in developing novel HIV vaccines-both preventative and therapeutic-and in developing a better understanding of AIDS pathogenesis.
|Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912|
|Mustanski, Brian; Parsons, Jeffrey T; Sullivan, Patrick S et al. (2018) Biomedical and Behavioral Outcomes of Keep It Up!: An eHealth HIV Prevention Program RCT. Am J Prev Med 55:151-158|
|Jenness, Samuel M; Goodreau, Steven M; Morris, Martina (2018) EpiModel: An R Package for Mathematical Modeling of Infectious Disease over Networks. J Stat Softw 84:|
|Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:|
|Eckard, Allison Ross; Raggi, Paolo; O'Riordan, Mary Ann et al. (2018) Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth. Virulence 9:294-305|
|Singleton, Robyn; Winskell, Kate; McLeod, Haley et al. (2018) Young Africans' social representations of sexual abuse of power in their HIV-related creative narratives, 2005-2014: cultural scripts and applied possibilities. Cult Health Sex :1-16|
|Hussen, Sophia A; Easley, Kirk A; Smith, Justin C et al. (2018) Social Capital, Depressive Symptoms, and HIV Viral Suppression Among Young Black, Gay, Bisexual and Other Men Who Have Sex with Men Living with HIV. AIDS Behav 22:3024-3032|
|Lahiri, Cecile D; Brown, Nakita L; Ryan, Kevin J et al. (2018) HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy. AIDS 32:2151-2159|
|Halpin, Sean N; Carruth, Edwin Clayton; Rai, Ramona P et al. (2018) Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment. AIDS Behav 22:848-852|
|Holloway, Ian W; Bednarczyk, Robert; Fenimore, Vincent L et al. (2018) Factors Associated with Immunization Opinion Leadership among Men Who Have Sex with Men in Los Angeles, California. Int J Environ Res Public Health 15:|
Showing the most recent 10 out of 1005 publications